US regulatory chief’s resignation raises alarms in biotech industry
FDA vaccines and biologicals centre director, Peter Marks, clashed with health secretary Robert F Kennedy Jr
Decoding 23andMe’s downfall
DNA testing firm’s bankruptcy raises data security questions
Welcome to the MegaPharm target selection and project resourcing meeting
Overheard recently in a seminar room near you…
Bayer ordered to pay more than $2 billion to US cancer victim
Jury decided glyphosate-based Roundup herbicide caused cancer, but company will appeal
Highlights
The glyphosate debate
The EU has recently approved the use of glyphosate for another decade. Bárbara Pinho examines the controversial pesticide’s presence in British farming and considers the possibility of a ban in the UK
Putting the F in pharma
Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame the ninth element
On the trail of the male contraceptive pill
As multiple novel male contraception compounds enter clinical trials, is family planning about to undergo a second revolution? James Mitchell Crow reports
The promise of drugs that send proteins to the shredder
Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to strategic discovery
Chemicals industry roundup 2024
Europe continues to struggle with high energy and feedstock costs, while US and Asia negotiate supply gluts
US regulatory chief’s resignation raises alarms in biotech industry
FDA vaccines and biologicals centre director, Peter Marks, clashed with health secretary Robert F Kennedy Jr
Welcome to the MegaPharm target selection and project resourcing meeting
Overheard recently in a seminar room near you…
Weight loss drug supply races
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of drugs
Ending of US weight-loss drug shortages prompts compounder complaints
Decision ends pharmacies’ permission to prepare versions of GLP-1 hormone mimics
US regulatory chief’s resignation raises alarms in biotech industry
FDA vaccines and biologicals centre director, Peter Marks, clashed with health secretary Robert F Kennedy Jr
How a herbicide illustrates the many ways chemicals are put to the test
The glyphosate debate highlights the complexity of chemicals regulation
Getting into the weeds of the glyphosate debate
Assessments of the risk posed by the controversial herbicide depend on how the evidence is weighed
US reviews chemical incident prevention planning rules
Risk Management Program has been extended and rolled back under successive governments
Weight loss drug supply races
With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of drugs
US drops chloroprene emissions lawsuit against Denka
Government says lawsuit stretched legal definitions in pursuit of ‘environmental justice’
Generative AI pipeline creates promising antimicrobial peptides
AI model extrapolates beyond training data to predict diverse antimicrobial structures
Far more drugs could be taken orally by formulating them with silica nanoparticles
Many more medicines could be made water soluble making taking them easier for patients
Mapping metabolite disturbances by drugs
High-throughput metabolomic profiling gives insight into unpredictable drug effects
Metal–organic framework captures carbon dioxide at industrially relevant temperatures
Material could improve energy efficiency of capturing carbon from industy’s exhaust gases
Fluorspar to fluorine chemicals without going via hazardous hydrogen fluoride
Safer way to turn calcium fluoride mineral into valuable industrial materials
Banned pigments found in tattoo inks sold in the EU
Nine out of 10 green and blue inks analysed violate Reach regulations
Nanopore sequencing set to transform our understanding of proteins
Rapid sequencing technique can not only deal with proteins hundreds of amino acids long but can detect modifications
How F1 plans to transition to ‘100% sustainable fuel’
Rule changes intend to make Formula One more environmentally friendly from 2026. But what are the changes, and can a sport known for gas-guzzling engines really go green?
Bayer ordered to pay more than $2 billion to US cancer victim
Jury decided glyphosate-based Roundup herbicide caused cancer, but company will appeal
How a herbicide illustrates the many ways chemicals are put to the test
The glyphosate debate highlights the complexity of chemicals regulation
Biomanufacturing proliferates in chemicals
Fermentation can improve sustainability at competitive costs
Chevron and BP cutting thousands of jobs
Oil industry is broadly looking to cut costs, increase oil and gas production and cut renewable investments
US drops chloroprene emissions lawsuit against Denka
Government says lawsuit stretched legal definitions in pursuit of ‘environmental justice’
New Trump tariffs worry North American chemical industries
High duties on imports from Canada, Mexico and China raise problems for international supply chains
Biomanufacturing proliferates in chemicals
Fermentation can improve sustainability at competitive costs
Dow to cut 1500 jobs as global chemicals industry reshapes
US firm joins other industry heavyweights in shedding jobs to cut costs
Eight workers dead in Indian munitions factory explosion
Seven others injured during incident at state-owned explosives plant
Red 3 dye banned in US food and drugs
Additive was already banned in US cosmetics and around the world
Dow to cut 1500 jobs as global chemicals industry reshapes
US firm joins other industry heavyweights in shedding jobs to cut costs
J&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
Sanofi spins out its consumer healthcare business
US-based investment firm takes controlling stake in Opella, while France’s government moves to ensure the company remains in the country
Adnoc to buy Covestro, continuing expansion into polymers
€15 billion deal sees Gulf oil producer looking to future growth beyond fuels
Pass or fail: rapid polymer analysis with FTIR
Your guide to quick and reliable verification of polymers with the Lyza 7000 FTIR spectrometer
Illuminating progress: recent advances in photoredox catalysis
In this free download, shed some light on the latest developments in photoredox for drug development and materials science
Digital tools for deft materials development
Discover how Microsoft can help you turn years of lab work into days of computation
